The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia
Laszlovszky, I., Dombi, Z.B., Balogh, Á., Barabássy, Á., Vass, G., Szatmári, B., Németh, G.
Published in European psychiatry (01.04.2021)
Published in European psychiatry (01.04.2021)
Get full text
Journal Article
Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials
Dombi, Z.B., Acsai, K., Barabássy, Á., Sebe, B., Laszlovszky, I., Vass, G., Szatmári, B., Patel, M., Earley, W., Németh, G.
Published in European psychiatry (01.04.2021)
Published in European psychiatry (01.04.2021)
Get full text
Journal Article
Safety during polypharmacy: A post-hoc analysis examining the safety profile of cariprazine with other antipsychotics in the cross-titration phase
Vass, G., Barabássy, Á., Laszlovszky, I., Sebe, B., Dombi, Z.B., Szatmári, B., Németh, G.
Published in European psychiatry (01.04.2021)
Published in European psychiatry (01.04.2021)
Get full text
Journal Article
Efficacy of cariprazine in negative, cognitive, and social function symptoms in schizophrenia: post hoc analysis of a randomized, controlled trial
Cutler, A.J, Durgam, S, Lu, K, Laszlovszky, I, Szalai, E, Edwards, J, Earley, W
Published in European neuropsychopharmacology (01.10.2016)
Published in European neuropsychopharmacology (01.10.2016)
Get full text
Journal Article
P.2.d.045 Global improvement in bipolar mania patients treated with cariprazine
Litman, R.E, Lu, K, Nagy, K, Laszlovszky, I, Durgam, S
Published in European neuropsychopharmacology (01.10.2014)
Published in European neuropsychopharmacology (01.10.2014)
Get full text
Journal Article
Cariprazine for negative symptoms of schizophrenia: pooled post hoc analysis of 2 randomized, double-blind, placebo- and active-controlled trials
Durgam, S, Earley, W, Lu, K, Németh, G, Laszlovszky, I, Szatmári, B, Edwards, J, Nasrallah, H.A
Published in European neuropsychopharmacology (01.10.2016)
Published in European neuropsychopharmacology (01.10.2016)
Get full text
Journal Article
Efficacy of cariprazine on predominant negative symptoms of patients with schizophrenia: post hoc analysis of PANSS data, Marder factors, and cognition
Marder, S, Laszlovszky, I, Szalai, E, Szatmári, B, Harsányi, J, Barabássy, A, Debelle, M, Durgam, S, Bitter, I, Németh, G
Published in European neuropsychopharmacology (01.10.2016)
Published in European neuropsychopharmacology (01.10.2016)
Get full text
Journal Article
P.3.d.073 Cariprazine and the reduction of hostility associated with schizophrenia
Citrome, L, Lu, K, Ferguson, P, Laszlovszky, I, Earley, W, Durgam, S
Published in European neuropsychopharmacology (01.09.2015)
Published in European neuropsychopharmacology (01.09.2015)
Get full text
Journal Article
P.2.d.014 Categorical improvement across mania symptoms: pooled analyses of cariprazine phase II/III trials
Durgam, S, Laszlovszky, I, Lu, K, Ruth, A, Debelle, M, Zukin, S
Published in European neuropsychopharmacology (01.09.2015)
Published in European neuropsychopharmacology (01.09.2015)
Get full text
Journal Article
P.3.d.053 Cariprazine as monotherapy for the treatment of schizophrenia patients with predominant negative symptoms: a double-blind, active controlled trial
Debelle, M, Németh, G, Szalai, E, Szatmári, B, Harsányi, J, Barabassy, A, Laszlovszky, I
Published in European neuropsychopharmacology (01.09.2015)
Published in European neuropsychopharmacology (01.09.2015)
Get full text
Journal Article
P.2.d.023 Safety and tolerability of cariprazine in patients with acute bipolar mania: pooled analysis of 3 phase II/III pivotal studies
Yatham, L.N, Vieta, E, Lu, K, Nagy, K, Laszlovszky, I, Earley, W, Durgam, S
Published in European neuropsychopharmacology (01.10.2014)
Published in European neuropsychopharmacology (01.10.2014)
Get full text
Journal Article
P.3.d.019 Categorical improvements in disease severity in schizophrenia patients treated with cariprazine
Volk, S, Zukin, S, Lu, K, Debelle, M, Laszlovszky, I, Durgam, S
Published in European neuropsychopharmacology (01.10.2014)
Published in European neuropsychopharmacology (01.10.2014)
Get full text
Journal Article
Monotherapy treatment with cariprazine for the treatment of predominant negative symptoms of patients with schizophrenia: A double-blind, active comparator-controlled trial
Németh, G, Debelle, M, Laszlovszky, I, Szalai, E, Szatmári, B, Harsányi, J, Barabássy, Á, Durgam, S, Bitter, I, Galderisi, S
Published in European psychiatry (01.03.2016)
Published in European psychiatry (01.03.2016)
Get full text
Journal Article
P.3.d.057 Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: a double-blind, placebo-controlled trial
Durgam, S, Earley, W, Li, R, Li, D, Lu, K, Laszlovszky, I, Fleischhacker, W.W, Lieberman, J.A
Published in European neuropsychopharmacology (01.09.2015)
Published in European neuropsychopharmacology (01.09.2015)
Get full text
Journal Article
Cariprazine in Negative Symptoms of Schizophrenia: Post-hoc Analyses of a Fixed-dose Phase Iii, Randomized, Double-blind, Placebo- and Active-controlled Trial
Debelle, M, Faradzs-zade, S, Szatmari, B, Nagy, K, Nemeth, G, Durgam, S, Laszlovszky, I
Published in European psychiatry (28.03.2015)
Published in European psychiatry (28.03.2015)
Get full text
Journal Article
P.3.d.023 Paliperidone palmitate long-acting injectable delays psychotic and mood symptom relapse in schizoaffective disorder
Fu, D.J, Alphs, L, Lindenmayer, J.P, Schooler, N, Nemeth, G, Durgam, S, Laszlovszky, I, Simonson, R.B, Turkoz, I, Walling, D
Published in European neuropsychopharmacology (01.10.2014)
Published in European neuropsychopharmacology (01.10.2014)
Get full text
Journal Article